Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Cellulitis

• Skin Inflammation and PK of Azithromycin
• Bioequivalence Study of Azithromycin Capsule and Reference Formulation Sumamed * in Healthy Adult Subjects in China
• Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial
• High-Dose Cephalexin for Cellulitis: A Randomized Controlled Trial
• Cellulitis Optimal Antibiotic Treatment
• Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca
• High-dose vs. Standard-dose Cephalexin for Cellulitis
• The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown
• Prevention of Vaginal Cellulitis or Vaginal Cuff Abscess After Laparoscopic Hysterectomy
• Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment
• Hospital Avoidance Strategies for ABSSSI
• Effectiveness of Alcohol Swabs for Preventing Infections During Vaccination
• Penicillin for the Emergency Department Outpatient Treatment of CELLulitis
• Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
• Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA
• Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence
• Comparing the Intravenous Treatment of Skin Infections in Children, Home Versus Hospital
• Human Immunity Against Staphylococcus Aureus Skin Infection
• Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
• Use of Corticosteroids in Children With Cellulitis
• Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
• Duration of ANtibiotic Therapy for CEllulitis
• Continuous Regional Anesthesia for Septic Limb Orthopedic Surgery
• Adjunctive Clindamycin for Cellulitis: C4C Trial.
• Bioequivalence Study for an Isotretinoin
• Individualized vs. Household MRSA Decolonization
• Retapamulin Microdialysis Feasibility Study
• Bioequivalence Minocycline Bioequivalence
• Use of a Single Dose of Oral Prednisone in the Treatment of Cellulitis
• The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin
• Phase 2a Study of CG400549 for the Treatment of cABSSSI Caused by Methicillin-resistant Staphylococcus Aureus
• Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections
• A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study
• A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci
• ALTARGO(Retapamulin) PMS(Post-marketing Surveillance)
• Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
• Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
• Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
• Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
• Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection
• Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection
• Direct Antibiotic Delivery of Cefazolin Into Soft Tissue Infections Using Subcutaneous Injection and Ultrasonic Dispersion
• A Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection
• A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease
• GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
• United States Pharmacovigilence Retapamulin-Prescribing
• Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees
• A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections
• Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)
• Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease
• Comparison of Intravenous Cefazolin Plus Oral Probenecid With Oral Cephalexin for the Treatment of Cellulitis
• Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers
• A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age
• A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients
• Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase
• The Use of Oral Steroids in the Treatment of Cellulitis
• Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA
• Staphylococcus Aureus Decolonization Study
• Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections
• Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
• Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL)
• Study of New Antibiotic Regimen for the Treatment of Uncomplicated Cellulitis in Emergency Department Patients
• Safety, Potential Efficacy, and Pharmacokinetics of PZ-601 in the Treatment of Complicated Skin and Skin Structure Infection
• Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections
• Complicated Skin and Skin Structure Infections
• A Randomized Clinical Trial to Prevent Recurrent CA-MRSA Infection
• Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.
• RCT to Investigate if Prophylactic Antibiotics Prevent Further Episodes of Cellulitis (Erysipelas) of the Leg
• A Study for Patients With Complicated Skin and Skin Structure Infections
• The Natural History of Community-Associated MRSA Infections and Decolonization Strategies
• First Time in Man Trial for Friulimicin B
• Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates
• Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome
• Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections
• TD-1792 in Gram-positive Complicated Skin and Skin Structure Infection
• Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections
• Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department
• Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas
• An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection in Soldiers
• A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Mild to Moderate Infections of the Skin and the Supportive Layers Beneath the Skin
• Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
• Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
• Evaluation of Antibacterial Soap for Treatment of Lymphedema in a Filariasis-Endemic Area
• Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo
• Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus
• Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus
• Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)